Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Public health and social measures to mitigate the health and economic impact of the COVID-19 pandemic in Turkey, Egypt, Ukraine, Kazakhstan, and Poland during 2020-2021: situational analysis.
KITAMURA, N; ABBAS, K; Nathwani, D;
2022
BMC public health, (2022).22 1 10.1186/s12889-022-13411-6.
COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery.
Toor, J; Li, X; JIT, M; Trotter, CL; Echeverria-Londono, S; Hartner, A-M; Roth, J; Portnoy, A; ABBAS, K; Ferguson, NM; Am Gaythorpe, K;
2022
Vaccine, (2022).40 31 10.1016/j.vaccine.2022.05.074.
WHO-led consensus statement on vaccine delivery costing: process, methods, and findings.
Levin, A; Boonstoppel, L; Brenzel, L; Griffiths, U; Hutubessy, R; JIT, M; Mogasale, V; Pallas, S; Resch, S; Suharlim, C; Yeung, KH T;
2022
BMC MEDICINE, (2022).20 1 10.1186/s12916-022-02278-4.
Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panel.
Miner, MD; Hatherill, M; Mave, V; Gray, GE; Nachman, S; Read, SW; WHITE, RG; Hesseling, A; Cobelens, F; Patel, S; Frick, M; Bailey, T; Seder, R; Flynn, J; Rengarajan, J; Kaushal, D; Hanekom, W; Schmidt, AC; Scriba, TJ; Nemes, E; Andersen-Nissen, E; Landay, A; Dorman, SE; Aldrovandi, G; Cranmer, LM; ... Churchyard, G.
2022
The lancet. HIV, (2022).9 11 10.1016/S2352-3018(22)00255-7.
Global and regional burden of attributable and associated bacterial antimicrobial resistance avertable by vaccination: modelling study.
Kim, C; Holm, M; Frost, I; Hasso-Agopsowicz, M; Abbas, K;
2022
medRxiv (2022). 10.1101/2022.05.08.22274821.
Vaccine equity in low and middle income countries: a systematic review and meta-analysis.
Ali, HA; Hartner, A-M; Echeverria-Londono, S; Roth, J; Li, X; ABBAS, K; Portnoy, A; VYNNYCKY, E; Woodruff, K; Ferguson, NM; Toor, J; Gaythorpe, KA;
2022
International Journal for Equity in Health, (2022).21 1 10.1186/s12939-022-01678-5.
"We don't have the same bodies; we don't react the same way": mothers and adolescent girls' perceptions of the risks and benefits of HPV vaccination in France.
KARAFILLAKIS, E; Peretti-Watel, P; Verger, P; CHANTLER, T; LARSON, HJ;
2022
HUMAN VACCINES & IMMUNOTHERAPEUTICS, (2022).18 1 10.1080/21645515.2022.2036555.
Improving Estimates of Social Contact Patterns for Airborne Transmission of Respiratory Pathogens.
MCCREESH, N; Mohlamonyane, M; Edwards, A; Olivier, S; Dikgale, K; Dayi, N; Gareta, D; Wood, R; GRANT, AD; WHITE, RG; Middelkoop, K;
2022
Emerging infectious diseases, (2022).28 10 10.3201/eid2810.212567.
Assessing the impacts of timing on the health benefits, cost-effectiveness and relative affordability of COVID-19 vaccination programmes in 27 African Countries.
LIU, Y; PEARSON, CA B; Madriz Montero, A; TORRES-RUEDA, S; Asfaw, E; Uzochukwu, B; Drake, T; Bergren, E; EGGO, R; RUIZ, F; Ndembi, N; Nonvignon, J; JIT, M; VASSALL, A;
2022
medRxiv (2022). 10.1101/2022.05.09.22274846.
The potential cost-effectiveness of HPV vaccination among girls in Mongolia.
Luvsan, M-E; Vodicka, E; Jugder, U; Tudev, U; CLARK, A; Groman, D; Otgonbayar, D; Demberelsuren, S; LaMongtagne, DS; Pecenka, C;
2022
Vaccine: X, (2022).11, 10.1016/j.jvacx.2022.100161.